Margaret A. Alexander, CEO of Ovid Therapeutics OVID, has filed 1 purchase and 2 sales on the open market. Over the past 12 months that comes to a net sale of $16.9K. The latest trade was on 02/26.

MA

MA

Margaret A. Alexander

President and CEO

Company

Ovid Therapeutics OVID

First filing

24/09/11

Trades

8 trades

Buys / sales

1 / 2

12-month net buying

−$16.9K

Last trade

02/26

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Ovid TherapeuticsOVID	Open-market sale	02/23	03/02	11,656 sh	$1.45	$16,901.2	−15.9%
Ovid TherapeuticsOVID	Open-market sale	25/02/26	25/02/28	5,279 sh	$0.56	$2,956.24	−6.7%
Ovid TherapeuticsOVID	Open-market buy	25/01/27	25/01/29	6,810 sh	$0.73	$4,971.3	+24.2%